COMMUNIQUÉS West-GlobeNewswire

Nicox: Notice of the Ordinary and Extraordinary Shareholders’ Meeting on June 24, 2026 and appointment of an ad hoc representative
03/06/2026
Press Release Nicox: Notice of the Ordinary and Extraordinary Shareholders’ Meeting on June 24, 2026 and appointment of an ad hoc representative June 3, 2026 – release at 7:30 am CET Sophia Antipolis, France Nicox SA ( [...]
Nicox : Convocation à l’Assemblée Générale Ordinaire et Extraordinaire le 24 juin 2026 et désignation d’un mandataire ad hoc
03/06/2026
Communiqué de presse Nicox : Convocation à l’Assemblée Générale Ordinaire et Extraordinaire le 24 juin 2026 et désignation d’un mandataire ad hoc 3 juin 2026 – publication à 7H30 Sophia Antipolis, France Nicox SA ( [...]
argenx Presents New Efgartigimod Data Showing Long-Term Sustained Patient Benefit in Myositis and Sjogren’s Disease at EULAR 2026
03/06/2026
ALKIVIA+ data in myositis indicate efgartigimod provides sustained, clinically meaningful improvements and consistent safety RHO+ data in Sjogren’s disease indicate maintenance of response following switch to biweekly [...]
Communiqué de presse : Sanofi fédère l'écosystème de santé pour accélérer le diagnostic des maladies rares en France : Biogen rejoint accelRare
03/06/2026
Sanofi fédère l’écosystème de santé pour accélérer le diagnostic des maladies rares en France : Biogen rejoint accelRare Paris, 3 juin 2026 - Sanofi annonce aujourd’hui l’arrivée de Biogen au sein d’ accelRare , outil [...]
Wegovy® pill launches in the UAE as Novo Nordisk expands global access to obesity care
03/06/2026
Novo Nordisk launches Wegovy ® pill in the United Arab Emirates today Wegovy ® pill is indicated to reduce excess body weight and maintain weight reduction long-term Wegovy ® pill, providing a mean weight loss of 17%, [...]
Chiesi Global Rare Diseases to Launch the Second Edition of Find For Rare at 2026 ERA Congress to Advance Research in Lysosomal Storage Disorders
03/06/2026
-- At ERA 2026, Chiesi will contribute to advancing the scientific understanding of Fabry disease and nephropathic cystinosis through real-world experience and clinical outcomes, supporting the needs of the community of [...]
Johnson & Johnson late-breaking results show nipocalimab significantly reduced systemic lupus erythematosus (SLE) disease activity in a Phase 2 study
03/06/2026
Nipocalimab – the first neonatal Fc receptor (FcRn) blocker to be studied in systemic lupus erythematosus – is designed to target and reduce pathogenic immunoglobulin G (IgG) autoantibodies associated with this disease [...]
JJP Biologics Announces Positive Interim Phase 1b Data for Nebaprubart (JJP-1212), an Anti-CD89 Antagonist, in Linear IgA Disease (LAD)
03/06/2026
Favorable safety and tolerability profile, with rapid onset of clinical activity and therapeutic effects observed in patients with LAD Data support the start of a Phase 1b clinical trial in rheumatoid arthritis, [...]
Inteleos and Medvarsity Partner to Expand Global POCUS Education Access
03/06/2026
New collaboration delivers the POCUS Fundamentals Certificate to clinicians worldwide, creating a structured entry point for point-of-care ultrasound training. ROCKVILLE, Md. and HYDERABAD, India, June 03, 2026 (GLOBE [...]
ASCO 2026 | Updated Data from an Oral Presentation of InnoCare's Novel BCL2 Inhibitor Mesutoclax in MDS and AML Released
03/06/2026
BEIJING, June 02, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that updated data [...]
Zenas BioPharma Announces Data from the Registrational Phase 3 INDIGO Trial of Obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD), Simultaneously Presented at the EULAR 2026 Congress and Published in the New England Journal of Medicine
03/06/2026
- The INDIGO study met its primary and all key secondary endpoints with statistically significant results - - Obexelimab significantly lowered the total amount of glucocorticoid use and reduced glucocorticoid-related [...]
Fortrea to Attend Jefferies Global Healthcare Conference
03/06/2026
DURHAM, N.C., June 02, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (“CRO”), today announced that that CEO Anshul Thakral, CFO Jill McConnell, and SVP of Investor [...]
DBV Technologies annonce le screening du premier participant de l’étude clinique de phase 2 THRIVE pour le patch VIASKIN® Peanut chez les nourrissons âgés de 6 à 12 mois allergiques à l’arachide
03/06/2026
Châtillon, France, le 02 juin (22 :30 CEST) 2026 DBV Technologies annonce le screening du premier participant de l’étude clinique de phase 2 THRIVE pour le patch VIASKIN ® Peanut chez les nourrissons âgés de 6 à 12 mois [...]
DBV Technologies Announces First Participant Screened in THRIVE Phase 2 Study of the VIASKIN® Peanut Patch in Infants ages 6 through 12 Months with Peanut Allergy
03/06/2026
Châtillon, France, June 2, 2026 DBV Technologies Announces First Participant Screened in THRIVE Phase 2 Study of the VIASKIN ® Peanut Patch in Infants ages 6 through 12 Months with Peanut Allergy The study is evaluating [...]
CAHI Honours The Honourable Don Boudria for Leadership in Animal Health
02/06/2026
OTTAWA, Ontario, June 02, 2026 (GLOBE NEWSWIRE) -- The Canadian Animal Health Institute (CAHI) is proud to announce the recipients of its 2026 Annual Awards, recognizing exceptional leadership and contributions to [...]
L’ICSA rend hommage à l’honorable Don Boudria pour son engagement envers la santé animale
02/06/2026
OTTAWA, Ontario, 02 juin 2026 (GLOBE NEWSWIRE) -- L’Institut canadien de la santé animale (ICSA) est fier d’annoncer les lauréats de ses prix annuels 2026, qui récompensent un engagement et des contributions [...]
Shopify Announces $3 Billion Increase to Share Repurchase Program
02/06/2026
Internet, Everywhere, June 02, 2026 (GLOBE NEWSWIRE) -- Shopify Inc. (NASDAQ, TSX: SHOP) today announced that its Board of Directors has authorized an additional $3 billion for the repurchase of Class A subordinate [...]
INVO Fertility Receives Nasdaq Notification Regarding Late Filing of Quarterly Report on Form 10-Q
02/06/2026
SARASOTA, Fla., June 02, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO” or the “Company”), a healthcare services fertility company, today announced that on May 27, 2026, it received a delinquency [...]
Cytek Biosciences to Unveil Next-Generation Spectral Flow Cytometry Innovations at CYTO 2026
02/06/2026
New 7-Laser Cytek Borealis™ System With Deep Ultraviolet and Infrared cFluor® Reagents; Cytek Aurora™ Evo System Enhancements for Automation and Workflow Efficiency FREMONT, Calif., June 02, 2026 (GLOBE NEWSWIRE) -- At [...]

Pages